Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Management of hepatitis B during pregnancy
Premashis Kar1, Saurabh Mishra1
1a Department of Medicine, Maulana Azad Medical College , University Of Delhi , New Delhi 110002 , INDIA.
Introduction:
Women of childbearing age or who are pregnant and have hepatitis B infection require specialized management both during and after pregnancy. Effective maternal screening along with judicious use of available antivirals and immunoprophylaxis greatly reduces the perinatal transmission of hepatitis B virus (HBV) and dramatically declines the incidence and prevalence of chronic hepatitis B and its sequelae.
Areas Covered:
A systematic literature search was done using Embase, Medline and Cochrane library from January 1990 to July 2015 and appropriate articles selected for this review. This review highlights the timing of therapy, choice of antiviral agent along with passive and active immunoprophylaxis for infants. Issues regarding breastfeeding in HBV-infected women and who are on antiviral therapy are addressed.
Expert Opinion:
All decisions about starting, continuing or stopping antiviral therapy must consider maternal and fetal risks. Antiviral therapy during the third trimester of pregnancy in women with active disease reduces the risk of perinatal transmission. Safety data in pregnancy are mostly available for lamivudine and tenofovir. However, recent studies have also advocated use of telbivudine in such patients. Detailed discussion with the patient regarding the risks and benefits of therapy is very important. Prophylaxis remains the best method of prevention of perinatal transmission.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cytomegalovirus Disease
Rh Blood Group
Mitral Valve Prolapse III: Nursing Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...